Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

One Company Dominates Wall Street on Oil Frenzy

The Dow Jones Industrial Average experienced volatility this year, facing multiple headwinds. Even so, a few stocks listed in the index performed well. Here's a look at four of them.

The Street

Dow Jones Falls On Inflation Data; Tesla Stock Hits New Low Amid Elon Musk Comments

The Dow Jones Industrial Average dropped Friday on key inflation data. Tesla stock hit a new low amid Elon Musk's comments on not selling shares.

Investors Business Daily

Dow Jones Dives After GDP, Jobless Data; CarMax Plunges On 'Vehicle Affordability Issues'

The Dow Jones dived more than 400 points Thursday after first-time jobless claims and GDP. CarMax plunged on "vehicle affordability issues."

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Rallies After Economic Data; Nike Surges 15% On Earnings; Tesla Hits New Low

The Dow Jones rallied 375 points Wednesday after consumer and housing data, as Nike stock surged 15% on strong earnings results.

Investors Business Daily

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Investors Business Daily

How A Bullish Risk Reversal Option Trade Works On Amgen Stock

Risk reversal option trades combine a short out-of-the-money put and a long out-of-the-money call. Here's how it works.

Investors Business Daily

The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen

Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Investors Business Daily

Stock Market Closes Higher Ahead Of Fed Meeting On Expected Lower Inflation; Energy, Tech Stocks Advance

Stock market gains ahead of Fed meeting on expected lower inflation. Database leader Box gains on upgrade.

Investors Business Daily

US biopharma firm Amgen to acquire Horizon Therapeutics for $28 bn

New York (AFP) - US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.

AFP

Amgen to buy Horizon Therapeutics in $26.4B deal

Horizon Therapeutics, whose U.S. headquarters is in Deerfield, is a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases.

Chicago Sun-Times

Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal

Amgen announced a $28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher.

Investors Business Daily

Dow Jones Rises Ahead Of Inflation Data, Fed Meeting; Amgen To Acquire Horizon Therapeutics

The Dow Jones Industrial Average rose Monday morning, as investors prepared for more inflation data and the Fed meeting this week.

Investors Business Daily

Amgen to buy Horizon Therapeutics in $26.4B deal

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Horizon Therapeutics Stock Surges On $28.5 Billion Amgen Takeover

"The acquisition of Horizon is a compelling opportunity for Amgen and the potential new medicines in Horizon's pipeline strongly complement our own R&D portfolio," said Amgen CEO Robert Bradway.

The Street

Stocks Edge Higher, Week Ahead, Microsoft, Boeing, Amgen - Five Things To Know

Stock futures edge higher into end-of-year push; Week Ahead: Fed Meeting highlights crucial series of central bank decisions; Boeing shares rise on report of Air India 737 Max deal; Microsoft takes 4% stake in London Stock Exchange Group and Horizon Therapeutics surges on report of $26 billion Amgen takeover.

Investors Business Daily

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up

Mirati said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed on questions about its market opportunity.

Investors Business Daily

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

Investors Business Daily

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Investors Business Daily

Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi

Horizon is considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 25% early Wednesday.

Benzinga

This US Representative Just Bought Shares Of Airbnb And These 2 Dividend-Paying Stocks

Congressman Josh Gottheimer (D-NJ) has made over 1,200 trades in the past three years, with his top two traded stocks being Microsoft (NASDAQ: MSFT) and Apple (NASDAQ: AAPL), reported b

Benzinga

Amgen Unusual Options Activity

Someone with a lot of money to spend has taken a bullish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Investors Business Daily

Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review

The stock market rally soared this week on a tame CPI inflation report. Bitcoin hit a two-year low while Meta and Tesla were in focus.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations